NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

NCT04698681 · clinicaltrials.gov ↗

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of Clinical Benefit

Conditions

Non-Small Cell Lung Cancer
Non-squamous Non-small-cell Lung Cancer
Non-Squamous Non-Small Cell Neoplasm of Lung
KEAP1 Gene Mutation
NRF2 Mutation
NFE2L2 Gene Mutation

Sponsor

Calithera Biosciences, Inc